Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

NCT04200651 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped COVID-19 challenges to recruitment

Conditions

Glaucoma
Cataract

Interventions

DRUG: Dexamethasone Ophthalmic Insert
DRUG: Prednisolone Acetate 1% Oph Susp

Sponsor

The New York Eye Surgery Center

Collaborators

[object Object]